Short Report

You have full text access to this OnlineOpen article

A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis

  1. Alexandra Nieters1,2,†,*,
  2. Paige M. Bracci3,
  3. Silvia de Sanjosé4,
  4. Nikolaus Becker1,
  5. Marc Maynadié5,
  6. Yolanda Benavente4,
  7. Lenka Foretova6,
  8. Pierluigi Cocco7,
  9. Anthony Staines8,
  10. Elizabeth A. Holly3,
  11. Paolo Boffetta9,
  12. Paul Brennan9,
  13. Christine F. Skibola10

Article first published online: 27 APR 2010

DOI: 10.1002/ijc.25420

Issue

International Journal of Cancer

International Journal of Cancer

Volume 128, Issue 6, pages 1481–1485, 15 March 2011

Additional Information

How to Cite

Nieters, A., Bracci, P. M., de Sanjosé, S., Becker, N., Maynadié, M., Benavente, Y., Foretova, L., Cocco, P., Staines, A., Holly, E. A., Boffetta, P., Brennan, P. and Skibola, C. F. (2011), A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis. Int. J. Cancer, 128: 1481–1485. doi: 10.1002/ijc.25420

Author Information

  1. 1

    Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany

  2. 2

    Molecular Epidemiology, Centre of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany

  3. 3

    Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA

  4. 4

    Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, CIBERESP, Barcelona, Spain

  5. 5

    Dijon University Hospital, Dijon, France

  6. 6

    Masaryk Memorial Cancer Institute, Brno, Czech Republic

  7. 7

    Department of Public Health, Occupational Health Section, University of Cagliari, Italy

  8. 8

    School of Nursing, Dublin City University, Dublin, Ireland

  9. 9

    International Agency for Research on Cancer, Lyon, France

  10. 10

    Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, CA

  1. †

    Tel.: [+49-(0)761-2707815], Fax: +[49-(0)761-2707760]

*Centre of Chronic Immunodeficiency, Molecular Epidemiology, University Medical Center Freiburg and University of Freiburg, Breisacher Straße 117, 2 OG, 79106 Freiburg

Publication History

  1. Issue published online: 28 JAN 2011
  2. Article first published online: 27 APR 2010
  3. Manuscript Accepted: 15 FEB 2010
  4. Manuscript Received: 5 OCT 2009

Funded by

  • German José Carreas Leukemia Foundation. Grant Number: DJCLS_R04/08 and R07/26f
  • Federal Ministry of Education and Research (BMBF). Grant Number: 01 EO 0803
  • EC 5th Framework Program Quality of Life. Grant Number: QLK4-CT-2000-00422
  • EC 6th Framework Program Food. Grant Number: FOOD-CT-2006-023103
  • Federal Office for Radiation Protection. Grant Number: StSch4261 and StSch4420 (Germany)
  • Spanish Ministry of Health grants CIBERESP. Grant Numbers: 06/02/0073, FIS 08-1555 and Marato TV3 (051210) (Spain)
  • La Fondation de France
  • Compagnia di San Paolo di Torino, Programma Oncologia 2001
  • National Cancer Institute. Grant Numbers: R01-CA45614, R01-CA89745, R01-CA87014, R01-CA104862 and R01-CA122663

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (281K)

References

  • 1
    Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 405–8.
  • 2
    Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 401–4.
  • 3
    Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007; 92: 960–9.
  • 4
    Tomer Y, Concepcion E, Greenberg DA. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002; 12: 1129–35.
  • 5
    Skibola CF, Nieters A, Bracci PM, Curry JD, Agana L, Skibola DR, Hubbard A, Becker N, Smith MT, Holly EA. A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 2008; 111: 4348–54.
  • 6
    Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 2005; 146: 2684–91.
  • 7
    Homig-Holzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Muller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis. J Exp Med 2008; 205: 1317–29.
  • 8
    De Sanjose S, Benavente Y, Nieters A, Foretova L, Maynadié M, Cocco PL, Staines A, Vornanen M, Boffetta P, Becker N, Alvaro T, Brennan P. The Effect of Regular Use of Hair Dye on Lymphoid Neoplasm in Europe. Am J Epidemiol 2006; 164: 47–55.
  • 9
    Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999; 150: 375–89.
  • 10
    Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 211–22.
  • 11
    Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, Concepcion E, Ho K, Tomer Y. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 2007; 8: 205–14.
  • 12
    Park JH, Chang HS, Park CS, Jang AS, Park BL, Rhim TY, Uh ST, Kim YH, Chung IY, Shin HD. Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE. Am J Respir Crit Care Med 2007; 175: 775–82.
  • 13
    Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111–35.
  • 14
    Saito M, Gao J, Basso K, Kitagawa Y, Smith PM, Bhagat G, Pernis A, Pasqualucci L, la-Favera R. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 2007; 12: 280–92.
View Full Article with Supporting Information (HTML) Get PDF (281K)